Inventor · disambiguated record
Jonathan Moss
Also filed as: MOSS JONATHAN · MOSS JONATHAN GO
16 granted patents·28 pending applications·524 citations·filing 1997–2023
93Inventor score
Top patents by PatentIndex Score
44 records- 0196US6608075B2Use of methylnaltrexone and related compoundsUNIV CHICAGO·Filed 2001·Granted Aug 19, 2003·88 cites·38 claims
- 0295US5972954AUse of methylnaltrexone and related compoundsARCH DEV CORP·Filed 1997·Granted Oct 26, 1999·222 cites·46 claims
- 0393US6559158B1Use of methylnaltrexone and related compounds to treat chronic opioid use side affectsUR LABS INC·Filed 2000·Granted May 6, 2003·79 cites·43 claims
- 0493US6274591B1Use of methylnaltrexone and related compoundsFiled 1998·Granted Aug 14, 2001·110 cites·30 claims
- 0584US9526723B2Treatment with opioid antagonists and mTOR inhibitorsUNIV CHICAGO·Filed 2014·Granted Dec 27, 2016·7 cites·5 claims
- 0682US8518962B2Use of opioid antagonistsMOSS JONATHAN·Filed 2010·Granted Aug 27, 2013·6 cites·5 claims
- 0776US2023181571A1Use of methylnaltrexone to attenuate tumor progressionSALIX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0875US8685995B2Treatment with opioid antagonists and mTOR inhibitorsMOSS JONATHAN·Filed 2009·Granted Apr 1, 2014·2 cites·16 claims
- 0975US2009312359A1Use of methylnaltrexone and related compounds for treatment of gastrointestinal dysfunction induced by endogenous opioidsFOSS JOSEPH F·Filed 2008·Application pending·0 cites
- 1074US8524731B2Use of opioid antagonists to attenuate endothelial cell proliferation and migrationMOSS JONATHAN·Filed 2006·Granted Sep 3, 2013·2 cites·10 claims
- 1174US2020163958A1Use of methylnaltrexone to attenuate tumor progressionSALIX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1270US9662390B2Use of opioid antagonists to attenuate endothelial cell proliferation and migrationMOSS JONATHAN·Filed 2006·Granted May 30, 2017·1 cites·4 claims
- 1369US2021121456A1Use of methylnaltrexone to attenuate tumor progressionSALIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1467US9662325B2Use of opioid antagonists to attenuate endothelial cell proliferation and migrationUNIV CHICAGO·Filed 2014·Granted May 30, 2017·0 cites·9 claims
- 1567US2010087472A1Use of methylnaltrexone and related compound to treat constipation in chronic opioid usersFOSS JOSEPH F·Filed 2009·Application pending·0 cites
- 1667US2021145825A1Use of opioid antagonistsUNIV CHICAGO·Filed 2020·Application pending·0 cites
- 1764US2004167148A1Oral use of methylnaltrexone and related compounds to treat constipation in chronic opioid usersFiled 2004·Application pending·0 cites
- 1864US2018008594A1Use of opioid antagonistsUNIV CHICAGO·Filed 2017·Application pending·0 cites
- 1964US2004162306A1Use of methylnal trexone and related compounds to treat constipation in chronic opioid usersFiled 2004·Application pending·0 cites
- 2063US2025186423A1Methods of treating cancer and other conditions with a mu opioid receptor antagonistGLYCYX MOR INC·Filed 2023·Application pending·0 cites
- 2161US9717725B2Use of opioid antagonistsUNIV CHICAGO·Filed 2013·Granted Aug 1, 2017·0 cites·9 claims
- 2260US2003158220A1Use of methylnaltrexone and related compounds to treat chronic opioid use side effectsFiled 2003·Application pending·0 cites
- 2360US2003065003A1Use of methylnaltrexone and related compoundsUNIV CHICAGO·Filed 2002·Application pending·0 cites
- 2459US2012277260A1Use of methylnaltrexone and related compounds to treat constipation in chronic opioid usersFOSS JOSEPH F·Filed 2012·Application pending·0 cites
- 2558US2012190702A1Use of methylnaltrexone and related compounds to treat constipation in chronic opioid usersFOSS JOSEPH F·Filed 2011·Application pending·0 cites
- 2658US2005048117A1Use of methylnaltrexone and related compoundsFiled 2004·Application pending·0 cites
- 2757US10383869B2Treatment with opioid antagonists and mTOR inhibitorsUNIV CHICAGO·Filed 2016·Granted Aug 20, 2019·0 cites·3 claims
- 2857US2004162307A1Use of methylnaltrexone and related compounds to induce laxation in chronic opioid usersFiled 2004·Application pending·0 cites
- 2957US2004162308A1Use of methylnaltrexone and related compounds for treatment of constipation caused by endogenous opioidsFiled 2004·Application pending·0 cites
- 3057US2004167147A1Oral use of methylnaltrexone and related compounds to induce laxation in chronic opioid usersFiled 2004·Application pending·0 cites
- 3156US2017202832A1Use of methylnaltrexone to attenuate tumor progressionSALIX PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3255US9675602B2Use of opioid antagonists to attenuate endothelial cell proliferation and migrationUNIV CHICAGO·Filed 2013·Granted Jun 13, 2017·0 cites·10 claims
- 3355US7372891B1Signal generator and decoderBRITISH TELECOMM·Filed 2000·Granted May 13, 2008·5 cites·4 claims
- 3455US2003187010A1Use of methylnaltrexone and related compounds to treat chronic opioid use side effectsFiled 2003·Application pending·0 cites
- 3554US2005011468A1Use of methylnaltrexone in treating gastrointestinal dysfunction in equinesFiled 2004·Application pending·0 cites
- 3654US2017252336A1Use of opioid antagonists to attenuate endothelial cell proliferation and migrationUNIV CHICAGO·Filed 2017·Application pending·0 cites
- 3753US2014142133A1Modulation of cell barrier dysfunctionUNIV CHICAGO·Filed 2013·Application pending·0 cites
- 3850US2008194611A1Modulation of Cell Barrier DysfunctionALVERDY JOHN C·Filed 2006·Application pending·0 cites
- 3948US2004259898A1Use of methylnaltrexone in treating gastrointestinal dysfunction in equinesFiled 2002·Application pending·0 cites
- 4047US2012316190A1Modulation of Cell Barrier DysfunctionALVERDY JOHN C·Filed 2012·Application pending·0 cites
- 4145US2017258909A1Use of opioid antagonists to attenuate endothelial cell proliferation and migrationUNIV CHICAGO·Filed 2017·Application pending·0 cites
- 4240US2003022909A1Use of methylnaltrexone to treat immune suppressionUNIV CHICAGO·Filed 2002·Application pending·0 cites
- 4337US6399036B1Use of solid hydroxides as scavenging materials for cyanide gasFiled 2000·Granted Jun 4, 2002·0 cites·10 claims
- 4431US6126612AMethod for detecting cyanide in cutaneously transpired gasFiled 1997·Granted Oct 3, 2000·2 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Jonathan Moss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →